Privia Health Group Inc
For the period ended Jun 30, 2024. Filed Aug 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 8, 2024
PRVA$24.37-0.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands)
| For the Six Months Ended June 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities | ||
| Net income | $7,699 | $12,762 |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||
| Depreciation | 585 | 581 |
| Amortization of intangibles | 3,054 | 2,449 |
| Stock-based compensation | 26,295 | 14,628 |
| Deferred tax expense | 3,896 | 3,259 |
| Changes in asset and liabilities: | ||
| Accounts receivable | (79,287) | (130,235) |
| Prepaid expenses and other current assets | (1,739) | (1,850) |
| Other non-current assets and right-of-use asset | (676) | 473 |
| Accounts payable and accrued expenses | 2,987 | (3,967) |
| Provider liability | 40,047 | 97,944 |
| Operating lease liabilities | (1,531) | (1,789) |
| Other long-term liabilities | — | (32) |
| Net cash provided by (used in) operating activities | 1,330 | (5,777) |
| Cash from investing activities | ||
| Business acquisitions, net of cash acquired | (707) | (24,856) |
| Other | (5,006) | (72) |
| Net cash used in investing activities | (5,713) | (24,928) |
| Cash flows from financing activities | ||
| Proceeds from exercised stock options | 1,224 | 5,783 |
| Repurchase of non-controlling interest | — | (5,694) |
| Contributed non-controlling interest | 1,000 | 569 |
| Net cash provided by financing activities | 2,224 | 658 |
| Net decrease in cash and cash equivalents | (2,159) | (30,047) |
| Cash and cash equivalents at beginning of period | 389,511 | 347,992 |
| Cash and cash equivalents at end of period | $387,352 | $317,945 |
| Supplemental disclosure of cash flow information: | ||
| Interest paid | $156 | $57 |
| Income taxes paid | $2,881 | $599 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.